Biomedical Research Center of the Slovak Academy of Sciences is the largest Slovak institution devoted to basic and applied research in biomedical sciences. BMC SAS was officially established on January 1st 2016 by merge of four previously independent SAS institutes, namely the Cancer Research Institute (CRI), the Institute of Clinical and Translational Research (ICTR, former Center for Molecular Medicine), the Institute of Experimental Endocrinology (IEE), and the Institute of Virology (IV). The principal mission of this novel research center is to foster research excellence, develop interdisciplinary approaches, and stimulate innovative potential for the improvement of our knowledge on human diseases, its better translation to clinic and more effective practical use for benefit of patients and the entire society. BMC SAS research is focused on understanding metabolic, neuroendocrine, autoimmune and cardiovascular disorders, cancer and infections, and their interrelationships when cooccurring in the same organisms.